Come up with a name for your new list and we'll add to it:
SynAgile raised a round of funding on August 24, 2017. Investors include
East Peak Capital.
SynAgile is developing DopaFuse, designed to be the first patient-friendly, noninvasive therapy for continuous delivery of L-DOPA and carbidopa. The medication is delivered from a small, comfortable d…